Retained Products. Fibrocell shall be permitted to continue the clinical development and Commercialization in the Field of any product resulting from the Fibroblast Program that, at the time of termination, satisfies at least one of the following criteria (a “Retained Product”):
Appears in 5 contracts
Samples: Exclusive Channel Collaboration Agreement (Fibrocell Science, Inc.), Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.)
Retained Products. Fibrocell shall be permitted to continue the clinical development and Commercialization in the Field of any product resulting from the Fibroblast Program that, at the time of termination, satisfies at least one of the following criteria (a “Retained Product”):
Appears in 1 contract
Samples: Channel Collaboration Agreement (Fibrocell Science, Inc.)
